Belgium’s food safety agency AFSCA-FAVV has ordered Ferrero to suspend production at its plant in Arlon, Belgium due to a link that has been confirmed between more than a hundred cases of salmonella and Kinder chocolate production.
According to AFSCA-FAVV, the decision to temporarily close the plant was taken after finding the information from Ferrero to be incomplete.
Ferrero, the Italian chocolate giant, canceled a number of its Kinder products last week owing to salmonella concerns.
The tainted chocolate was made at Ferrero's Arlon plant, where salmonella was discovered in a filter in December.
According to the Food Standards Agency in the United Kingdom, at least 63 instances of salmonella have been connected to Kinder products, with the majority of the cases occurring in children under the age of five.
Other countries affected by recalls included the US and several European states.
Ferrero acknowledged internal inefficiencies that caused delays in retrieving and sharing information promptly.
Ferrero revealed that the plant would only reopen once certified by the authorities.


Henkel in Advanced Talks to Acquire Olaplex at $2 Per Share
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
FDA Biologics Chief Vinay Prasad to Leave Agency in April Amid Policy Disputes
U.S. Jobs Market Eyes March Recovery Amid Inflation Pressures
ECB Eyes Rate Hike Amid Iran Conflict-Driven Energy Price Surge
Lynas Rare Earths Signs Vietnam Deal with LS Eco Energy to Boost Magnet Metal Production
Australia's Energy Crisis: Free Public Transport as Fuel Shortages Bite
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Asian Currencies Hold Steady as Dollar Stays Firm Amid Middle East Uncertainty
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
CDC Acting Director Urges Measles Vaccination as U.S. Cases Surge in 2026 



